Jon Zugazagoitia
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 52
- Cancer Immunotherapy and Biomarkers 29
- Lung Cancer Research Studies 20
- CAR-T cell therapy research 10
-
- Lung Cancer Treatments and Mutations 20
- Co-authors
- David L. Rimm (19 shared papers)Roy S. Herbst (10 shared papers)Scott Gettinger (4 shared papers)Luis Paz‐Ares (27 shared papers)Kurt A. Schalper (6 shared papers)Yuting Liu (5 shared papers)Fahad Shabbir Ahmed (4 shared papers)Brian S. Henick (3 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Oncology (11 papers)Journal of Thoracic Oncology (9 papers)Cancer Research (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Jon Zugazagoitia
68 papers receiving 1.7k citations
Jon Zugazagoitia's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 1.0k
- Immunology 386
- Pulmonary and Respiratory Medicine 459
- Cancer Research 144
- Epidemiology 153
Countries citing papers authored by Jon Zugazagoitia
This map shows the geographic impact of Jon Zugazagoitia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Zugazagoitia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Zugazagoitia more than expected).
Fields of papers citing papers by Jon Zugazagoitia
This network shows the impact of papers produced by Jon Zugazagoitia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Zugazagoitia. The network helps show where Jon Zugazagoitia may publish in the future.
Co-authors
The 25 scholars most cited alongside Jon Zugazagoitia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 232 | |
| 2 | 2019 | 225 | |
| 3 | 2015 | 157 | |
| 4 | At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC Hit paper breakdown → | 2023 | 93 |
| 5 | 2020 | 87 | |
| 6 | 2018 | 78 | |
| 7 | 2019 | 72 | |
| 8 | 2017 | 62 | |
| 9 | 2019 | 50 | |
| 10 | 2014 | 49 | |
| 11 | 2021 | 41 | |
| 12 | 2017 | 36 | |
| 13 | 2020 | 33 | |
| 14 | 2016 | 32 | |
| 15 | 2022 | 28 | |
| 16 | 2024 | 27 | |
| 17 | 2022 | 27 | |
| 18 | 2020 | 25 | |
| 19 | 2020 | 22 | |
| 20 | 2021 | 20 |
About Jon Zugazagoitia
Jon Zugazagoitia is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 79 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (29 papers), Lung Cancer Research Studies (20 papers), Lung Cancer Treatments and Mutations (20 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Research and Treatments (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (386 citations), Pulmonary and Respiratory Medicine (459 citations), Cancer Research (144 citations) and Epidemiology (153 citations). Jon Zugazagoitia has collaborated with scholars based in Spain, United States and France. Frequent co-authors include David L. Rimm, Roy S. Herbst, Scott Gettinger, Luis Paz‐Ares, Kurt A. Schalper, Yuting Liu, Fahad Shabbir Ahmed, Brian S. Henick, Ana B. Enguita and Álvaro C. Ucero. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.